Literature DB >> 29310917

Mid-Term Results of Graft Augmentation Prosthesis II Cage and Impacted Allograft Bone in Revision Hip Arthroplasty.

Hazem A H Hosny1, Ahmed El-Bakoury1, Helmy Fekry2, Jonathan Keenan2.   

Abstract

BACKGROUND: Several techniques have been described for management of severe acetabular bone defects during revision hip surgery including reconstructive cages. The purpose of this study is to analyze the survival and the mid-term clinical and radiological outcome using the Graft Augmentation Prosthesis (GAP II cage) (Stryker Orthopaedics, Mahwah, NJ) in addition to impaction grafting for acetabular defects in revision hip surgery.
METHODS: This is a retrospective review of all patients who underwent acetabular revision hip replacement using GAP II cage and impaction bone grafting between 2009 and 2013 at our institution. Twenty-six patients were included with a mean age of 71 years (49-91). According to Paprosky classification, 2 patients had type IIB defect, 4 had type IIC, and 12 had type IIIA, while 8 suffered from type IIIB defect. The clinical outcome was assessed using Oxford Hip Score. Plain radiographs were used to assess preoperative bone loss, postoperative implant migration, and the incorporation of the bone graft to host bone.
RESULTS: The average Oxford Hip Score improved from 11.3 (2-22) preoperatively to 32.2 (20-48) postoperatively. The revision free survivorship of this construct was 100% at mean follow-up of 49 months (30-78). Three hips had radiological failure of the implant with no clinical consequences.
CONCLUSION: The use of GAP II cage with impaction bone grafting to reconstruct severe acetabular defects had encouraging mid-term results with low failure rate. Graft incorporation with restoration of bone stock may be beneficial should further revision surgery be needed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GAP II cage; acetabular defects; impaction grafting; pelvic discontinuity; revision hip arthroplasty

Mesh:

Year:  2017        PMID: 29310917     DOI: 10.1016/j.arth.2017.11.060

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Three-dimensional-printed titanium implants for severe acetabular bone defects in revision hip arthroplasty: short- and mid-term results.

Authors:  Sheng Fang; Yiming Wang; Peng Xu; Junke Zhu; Jinbo Liu; Huan Li; Xiaoliang Sun
Journal:  Int Orthop       Date:  2022-04-06       Impact factor: 3.479

2.  Total hip arthroplasty, combined with a reinforcement ring and posterior column plating for acetabular fractures in elderly patients: good outcome in 34 patients.

Authors:  Tõnis Lont; Jyrki Nieminen; Aleksi Reito; Toni-Karri Pakarinen; Ilari Pajamäki; Antti Eskelinen; Minna K Laitinen
Journal:  Acta Orthop       Date:  2019-04-01       Impact factor: 3.717

3.  The mid-long term results of reconstructional cage and morselized allografts combined application for the Paprosky type III acetabular bone defects in revision hip arthroplasty.

Authors:  Qiang Xiao; Haoyang Wang; Kai Zhou; Duan Wang; Tingxian Ling; Fuxing Pei; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2019-11-07       Impact factor: 2.362

4.  Outcome and EBRA migration analysis of a reconstruction cage in acetabular revision arthroplasty: a clinical and radiological study.

Authors:  Dietmar Dammerer; Philipp Blum; David Putzer; Annelies van Beeck; Michael Nogler; Martin Thaler
Journal:  Arch Orthop Trauma Surg       Date:  2020-12-22       Impact factor: 3.067

5.  Acetabular Revision Surgery with Tantalum Trabecular Metal Acetabular Cup for Failed Acetabular Cage Reconstruction with Bone Allografts: A Retrospective Study with Mid- to Long-Term Follow-Up.

Authors:  Chen-Heng Hsu; Chih-Chien Hu; Chih-Hsiang Chang; Yu-Han Chang; Hsin-Nung Shih; Chun-Chieh Chen
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

Review 6.  Pelvic discontinuity: a challenge to overcome.

Authors:  George C Babis; Vasileios S Nikolaou
Journal:  EFORT Open Rev       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.